Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycle
about
Immune and non-immune responses to hepatitis C virus infectionGenetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine DesignHuman Choline Kinase-α Promotes Hepatitis C Virus RNA Replication through Modulation of Membranous Viral Replication Complex FormationProteomic approaches to analyzing hepatitis C virus biologyQuantitative Proteomics Analysis of the Hepatitis C Virus Replicon High-Permissive and Low-Permissive Cell LinesThe missing pieces of the HCV entry puzzle.Regulated Entry of Hepatitis C Virus into Hepatocytes.A CRISPR-Based Screen Identifies Genes Essential for West-Nile-Virus-Induced Cell Death.Genetic Dissection of the Host Tropism of Human-Tropic Pathogens.Identification of HNRNPK as regulator of hepatitis C virus particle production.Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine modelAssociation of a variant in the regulatory region of NADPH oxidase 4 gene and metabolic syndrome in patients with chronic hepatitis CDynamic Interaction of Stress Granules, DDX3X, and IKK-α Mediates Multiple Functions in Hepatitis C Virus InfectionThe SUMOylation Pathway Restricts Gene Transduction by Adeno-Associated VirusesPim Kinase Interacts with Nonstructural 5A Protein and Regulates Hepatitis C Virus Entry.Identification of Entry Factors Involved in Hepatitis C Virus Infection Based on Host-Mimicking Short Linear Motifs.The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry.Ankyrin Repeat Domain 1 is Up-regulated During Hepatitis C Virus Infection and Regulates Hepatitis C Virus Entry.Nonstructural 5A Protein of Hepatitis C Virus Regulates Soluble Resistance-Related Calcium-Binding Protein Activity for Viral Propagation.A human genome-wide loss-of-function screen identifies effective chikungunya antiviral drugsHepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition.Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway.GRIM-19 Restricts HCV Replication by Attenuating Intracellular Lipid Accumulation.Hepatitis C Virus Subverts Human Choline Kinase-α To Bridge Phosphatidylinositol-4-Kinase IIIα (PI4KIIIα) and NS5A and Upregulates PI4KIIIα Activation, Thereby Promoting the Translocation of the Ternary Complex to the Endoplasmic Reticulum for ViralCooperation between the Hepatitis C Virus p7 and NS5B Proteins Enhances Virion Infectivity.HuR Displaces Polypyrimidine Tract Binding Protein To Facilitate La Binding to the 3' Untranslated Region and Enhances Hepatitis C Virus Replication.The spliceosome factor SART1 exerts its anti-HCV action through mRNA splicing.Human embryonic stem cell-derived hepatoblasts are an optimal lineage stage for hepatitis C virus infection.Infection of Hepatocytes With HCV Increases Cell Surface Levels of Heparan Sulfate Proteoglycans, Uptake of Cholesterol and Lipoprotein, and Virus Entry by Up-regulating SMAD6 and SMAD7.SMAD About Hepatitis C Virus Cell Entry and Liver Disease.A review of computational approaches for analysis of hepatitis C virus-mediated liver diseases.Cellular microRNA networks regulate host dependency of hepatitis C virus infection.N-Myc Downstream-Regulated Gene 1 Restricts Hepatitis C Virus Propagation by Regulating Lipid Droplet Biogenesis and Viral Assembly.Hepatitis C virus-induced prion protein expression facilitates hepatitis C virus replication.Phosphorylated E2F1 is stabilized by nuclear USP11 to drive Peg10 gene expression and activate lung epithelial cells.Phosphoproteomic analysis reveals Smad protein family activation following Rift Valley fever virus infection.Fatty Acid Synthase induced S6Kinase facilitates USP11-eIF4B complex formation for sustained oncogenic translation in DLBCL.Oncogenic Signaling Induced by HCV InfectionCurrent and future targets of antiviral therapy in the hepatitis C virus life cycleHA1077 displays synergistic activity with daclatasvir against hepatitis C virus and suppresses the emergence of NS5A resistance-associated substitutions in mice
P2860
Q26782040-302EA360-2295-4F2D-A3C6-7CA1B5E64619Q26801759-BBB62E41-B9C5-4BA7-B941-316110EA4F73Q27468561-E3AB2F5F-41AB-47AC-99CE-5B853B2F01A6Q28085146-FCB2F43C-E079-4EE4-A129-3E7A3FDE7F10Q28550751-066492EA-AA40-4E70-A023-717F6EEBE88FQ33360674-FD68CF29-5441-4581-BA5A-03A5C4F7BC48Q33753913-2A6FFF7B-D9B5-4659-BADC-182AD288E0E4Q34485801-8F34926B-B211-412E-9AED-5663D26018E6Q34495762-18E00B60-0CF1-4A44-A4E0-B6BD02C3DE97Q34875666-DD00EBDF-49F2-4585-AC9C-FE3C0871EE4AQ35140067-65D3394D-6D59-42F0-84FF-43249E02B7B6Q35247372-EE4AADC7-DF16-4735-96E5-409604E14242Q35641517-0AC8E278-F8BE-452F-AD23-DEF42F4873FCQ35857358-E31CCECE-058F-4CF9-9CA1-8D9AC2B1A29EQ36080785-5D777FC8-11E6-4851-86C7-1DA2BBB0253AQ36262482-A5545050-A138-4881-8EA4-404C0C928315Q36283505-36D47FCA-7F11-46EE-AA72-EAC2EB32E94CQ36565565-32AB36C1-C0C2-41BF-B2B0-B15F27F164E6Q36736693-BD75387B-121B-4AF8-BD0B-D8252864E55EQ36897996-6D39070A-FFD3-4A15-8486-C394530829C5Q37086661-38FF9FAB-2C31-4F53-85F4-9C5EA793EB51Q37534152-8081BAF7-D03D-4317-9C70-A5654DB02818Q37747068-E69B115C-37F6-4976-916C-24442D6A9EB4Q38701691-9EDCDF34-ACE7-436F-8FCA-E3A65F684CE9Q38836459-F146980C-E2A0-4776-AD7D-548C415A6582Q38838070-C4D990CF-95A5-4C2B-ADE5-D293E25CD838Q39816699-CF1D7BAE-87C3-4A88-B14B-22C871552C2BQ40318294-68048A4F-FAA6-454F-9A77-87BAA2D425A2Q40520129-C8F45500-6F58-454A-9992-7E3F68914B95Q42320803-0201CF82-9F85-494B-800D-DEE28E4E8E0AQ45323934-15348AD8-874E-44C8-8F80-30C4656B1BE4Q45324234-EA3A93D3-D773-4247-9D13-4FCF02F310AFQ45325110-3044958B-8F78-46DB-8345-1285D96BE23AQ45325599-42008A77-B53C-4674-AACD-280B6F04615CQ47243705-DF45DD8D-D48F-4188-A6C3-9EBCE17D4A6AQ48097495-1A82817A-7AA6-450A-82C8-DD80A23AC525Q52372502-AD2D4E05-3016-4645-9BC1-1411FA05B2C3Q57050806-827B0DC0-9A62-44D7-9F31-1304844A1C33Q57071775-55F96D98-1F2A-4F66-87F5-92771035A93EQ58737372-C8469312-BD1F-4DEB-9C09-AC435E408E39
P2860
Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycle
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Integrative functional genomic ...... mplete viral replication cycle
@ast
Integrative functional genomic ...... mplete viral replication cycle
@en
type
label
Integrative functional genomic ...... mplete viral replication cycle
@ast
Integrative functional genomic ...... mplete viral replication cycle
@en
prefLabel
Integrative functional genomic ...... mplete viral replication cycle
@ast
Integrative functional genomic ...... mplete viral replication cycle
@en
P2093
P2860
P1433
P1476
Integrative functional genomic ...... mplete viral replication cycle
@en
P2093
Catherine Sodroski
Ching-Sheng Hsu
Emmanuel Thomas
Fang Zhang
Keng-Hsin Lan
Qisheng Li
Stephan Chiu
T Jake Liang
Yong-Yuan Zhang
P2860
P304
P356
10.1371/JOURNAL.PPAT.1004163
P577
2014-05-22T00:00:00Z